Decay of Fc-dependent antibody functions after mild to moderate COVID-19
View ORCID ProfileWen Shi Lee, Kevin John Selva, Samantha K. Davis, Bruce D. Wines, Arnold Reynaldi, Robyn Esterbauer, Hannah G. Kelly, Ebene R. Haycroft, Hyon-Xhi Tan, Jennifer A. Juno, Adam K. Wheatley, P. Mark Hogarth, Deborah Cromer, Miles P. Davenport, Amy W. Chung, Stephen J. Kent
doi: https://doi.org/10.1101/2020.12.13.20248143
Wen Shi Lee
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
Kevin John Selva
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
Samantha K. Davis
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
Bruce D. Wines
2Immune Therapies Group, Burnet Institute, Melbourne, VIC, Australia
3Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia
4Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia
Arnold Reynaldi
5Kirby Institute, University of New South Wales, Kensington, NSW, Australia
Robyn Esterbauer
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
Hannah G. Kelly
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
Ebene R. Haycroft
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
Hyon-Xhi Tan
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
Jennifer A. Juno
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
Adam K. Wheatley
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
6Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia
P. Mark Hogarth
2Immune Therapies Group, Burnet Institute, Melbourne, VIC, Australia
3Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia
4Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia
Deborah Cromer
5Kirby Institute, University of New South Wales, Kensington, NSW, Australia
Miles P. Davenport
5Kirby Institute, University of New South Wales, Kensington, NSW, Australia
Amy W. Chung
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
Stephen J. Kent
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty institute for Infection and Immunity, Melbourne, VIC, Australia
6Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia
7Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia
Article usage
Posted December 14, 2020.
Decay of Fc-dependent antibody functions after mild to moderate COVID-19
Wen Shi Lee, Kevin John Selva, Samantha K. Davis, Bruce D. Wines, Arnold Reynaldi, Robyn Esterbauer, Hannah G. Kelly, Ebene R. Haycroft, Hyon-Xhi Tan, Jennifer A. Juno, Adam K. Wheatley, P. Mark Hogarth, Deborah Cromer, Miles P. Davenport, Amy W. Chung, Stephen J. Kent
medRxiv 2020.12.13.20248143; doi: https://doi.org/10.1101/2020.12.13.20248143
Decay of Fc-dependent antibody functions after mild to moderate COVID-19
Wen Shi Lee, Kevin John Selva, Samantha K. Davis, Bruce D. Wines, Arnold Reynaldi, Robyn Esterbauer, Hannah G. Kelly, Ebene R. Haycroft, Hyon-Xhi Tan, Jennifer A. Juno, Adam K. Wheatley, P. Mark Hogarth, Deborah Cromer, Miles P. Davenport, Amy W. Chung, Stephen J. Kent
medRxiv 2020.12.13.20248143; doi: https://doi.org/10.1101/2020.12.13.20248143
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (678)
- Anesthesia (182)
- Cardiovascular Medicine (2678)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12310)
- Forensic Medicine (10)
- Gastroenterology (769)
- Genetic and Genomic Medicine (4158)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2694)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2071)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (461)
- Public and Global Health (6578)
- Radiology and Imaging (1420)
- Respiratory Medicine (876)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)